Every Thursday we send out a curated newsletter on “all things femtech and women’s health innovation”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.
“Eli is developing a device that uses saliva to capture hormone fluctuations at home, and an app that provides powerful information daily based on each user’s evolving hormonal profile.”
Highlights
Intimate care brand Queen V is acquired by Reckitt Benckiser; Hormone tracking startup Eli raises a $1.5M seed round; Hormonal Health startup Aavia launches their mobile app and announces last year’s $2.5M seed round; MobileODT is awarded a $2.3M grant from the National Cancer Institute; Philipps and Merck partner to advance personalized fertility treatment; Family benefits company Cleo expands their leadership team; Pill Club announces former Uber Eats Co-Founder Liz Meyerdirk as new CEO; DTC women’s health brand Stix launches a new line of products to test and treat UTIs; Hims & Hers goes public in $1.6B SPAC deal; Berlin-based healthtech investor Heal Capital closes a €100M fund
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
